Many people wonder whether they will need a GLP-1 medication forever. Some stop because of cost, side effects, insurance changes or because they reached a goal. Whatever the reason, it helps to know what research shows about stopping, so you and your prescriber can plan for it.
Key takeaways
- When people stop a GLP-1, appetite usually returns over a few weeks as the drug leaves the body.
- Large trials show most people regain a meaningful amount of lost weight within a year of stopping.
- Health markers like blood pressure, blood sugar and cholesterol can also drift back as weight returns.
- Planning ahead with your prescriber, staying active and tracking progress can help, but no plan has been proven to prevent regain.
- Never stop a GLP-1 used for diabetes without talking to your prescriber first.
Why these drugs are seen as long-term treatment
Obesity and type 2 diabetes are long-term conditions. GLP-1 medicines work while they are in your body. They lower appetite, slow stomach emptying and help control blood sugar. They do not permanently reset the body's weight regulation. FDA labels for weight-management GLP-1s describe them as treatment to "reduce excess body weight and maintain weight reduction long term." That wording reflects how they are studied and used.
What happens in your body after the last dose
The drug clears slowly
Weekly GLP-1s leave the body over several weeks. The Wegovy label says semaglutide has a half-life of about one week and remains in circulation for about 5 to 7 weeks after the last dose. Effects tend to fade gradually, not overnight.
Appetite comes back
As drug levels fall, many people notice stronger hunger, larger portions feeling normal again and more thoughts about food. This is expected. The medicine was quieting these signals, and they return when it is gone.
Digestion changes
Stomach side effects like nausea often improve after stopping. Some people find that foods they had trouble with feel fine again.
What the research shows about weight
Two large trials tested this directly. People took the medication for a period of time, then some were switched to placebo without knowing it.
| Trial | Medication | What happened after switching to placebo |
|---|---|---|
| STEP 4 (2021) | Semaglutide | After 20 weeks on drug, those who switched to placebo gained about 6.9% of body weight by week 68, while those who stayed on lost another 7.9% |
| SURMOUNT-4 (2024; follow-up 2025) | Tirzepatide | After 36 weeks on drug, 82% of those switched to placebo regained at least 25% of the weight they had lost within one year |
A 2025 joint advisory from four obesity and nutrition groups summed it up this way: weight regain is common, with up to two-thirds of lost weight regained within a year, even when people receive standard diet or behavior counseling.
These are group averages. In SURMOUNT-4, a smaller group regained less than a quarter of their lost weight. Individual results vary a lot.
What happens to health markers
Weight is not the only thing that can change. A 2025 follow-up analysis of SURMOUNT-4 found that people who regained more weight also saw larger reversals in earlier improvements, including waist size, blood pressure, cholesterol, A1C and fasting insulin. People who regained less than a quarter of their lost weight kept most of those improvements.
For people with type 2 diabetes, stopping can mean higher blood sugar. That is why diabetes medication changes should always be planned with your prescriber, who may need to adjust other medicines.
A concern about muscle
The same joint advisory noted that stopping and starting, weight cycling and regain may raise the risk of losing muscle while regaining fat. Weight that comes back tends to include more fat than the weight that was lost. Strength training and enough protein while on treatment may help protect lean mass. See GLP-1s and muscle loss.
Planning ahead if you need to stop
No approach has been proven in controlled trials to prevent regain after stopping. Still, these steps can help you and your prescriber respond early.
Make the decision together
Talk about why you want to stop, whether a lower maintenance dose or a different medication might work, and what the follow-up plan looks like. Some prescribers lower the dose gradually. Ask what they recommend for you.
Build habits while you are still on the medication
The time on treatment is a good window to build routines that are easier while appetite is lower: regular meals with protein, strength training, daily movement, good sleep and limiting alcohol. The CDC recommends adults get at least 150 minutes of moderate activity and muscle-strengthening activity on at least two days each week.
Track more than the scale
Watch weight, waist size, blood pressure if you have a home cuff, energy and hunger levels. Catching a trend early gives you time to act. Our guide to tracking progress beyond the scale explains how, and the PepSteady app can log these in one place.
Set a check-in point
Agree with your prescriber on what change would prompt a visit, such as a certain amount of regain or a rise in blood sugar. That way you are not guessing.
Be kind to yourself
Regain after stopping is a biological response, not a personal failure. It is the same pattern seen when people stop blood pressure or cholesterol medicine and their numbers rise again.
If cost is the reason
Cost is one of the most common reasons people stop. Before you stop, ask your prescriber and pharmacist about generic liraglutide, oral options, coverage appeals or patient assistance programs. Our post on brand-name vs. compounded GLP-1s explains why unapproved online sources are not a safe way to save money.
The bottom line
When people stop a GLP-1, appetite returns and most regain a meaningful share of lost weight within a year, along with some health markers. That does not mean you can never stop, but it does mean stopping deserves a plan. Make the decision with your prescriber, build habits while on treatment and track your progress afterward.
Sources
- Wegovy prescribing information (FDA)
- STEP 4: weight loss maintained with weekly semaglutide (Healio)
- SURMOUNT-4: weight reversal after tirzepatide withdrawal (American College of Cardiology)
- Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory (PMC)
- Adult physical activity guidelines (CDC)
Frequently asked questions
Will I regain all the weight if I stop my GLP-1?
Not necessarily all of it, but studies show most people regain a meaningful share. In the SURMOUNT-4 trial, 82% of people switched to placebo regained at least a quarter of the weight they had lost within one year. Results vary from person to person.
How long does semaglutide stay in your body after the last dose?
The Wegovy label says semaglutide has a half-life of about one week and stays in circulation for about 5 to 7 weeks after the last dose. Effects on appetite usually fade during that time.
Should I taper off a GLP-1 instead of stopping suddenly?
Some prescribers lower the dose gradually, others stop it outright. There is not yet strong evidence on the best approach, so make the plan with your prescriber.